Related Experiment Video
Updated: Dec 27, 2025

Use of a Linear Accelerator for Conducting In Vitro Radiobiology Experiments
Published on: May 26, 2019
[Biologic effects of high doses per fraction]
1Service d'oncologie-radiothérapie, hôpitaux universitaires Henri-Mondor, CHU de Henri-Mondor, université Paris-Est-Créteil, AP-HP, 51, avenue Mal-De-Lattre-de-Tassigny, 94000 Créteil, France.
High doses per fraction radiotherapy presents unique radiobiological challenges, differing from conventional treatments. New techniques like flash irradiation show promise for better normal tissue tolerance and anti-tumor efficacy.
Area of Science:
- Radiation Oncology
- Radiobiology
- Cancer Research
Background:
- Conventional radiobiology models, based on 1.8 to 2Gy per fraction, face challenges when applied to high dose per fraction (HDF) irradiation.
- HDF involves distinct mechanisms, including vascular microenvironment damage and anti-tumor immune responses, potentially diminishing the role of classical radiobiology principles like the "5Rs".
Purpose of the Study:
- To explore the complexities of radiobiological concepts in high dose per fraction (HDF) radiotherapy.
- To discuss the limitations of current models, such as the linear-quadratic model, in predicting HDF outcomes.
- To highlight the potential of novel irradiation techniques, including flash irradiation, and the need for clinical validation.
Main Methods:
- Review of radiobiological principles relevant to conventional and high dose per fraction radiotherapy.
- Discussion of the limitations of the linear-quadratic model for HDF scenarios.
- Consideration of emerging techniques like flash irradiation and their radiobiological underpinnings.
Main Results:
- Classical radiobiological concepts and the linear-quadratic model may not accurately predict outcomes for HDF radiotherapy.
- High dose per fraction irradiation involves specific mechanisms impacting the tumor microenvironment and immune response.
- Flash irradiation, a high dose rate technique, demonstrates potential for improved normal tissue tolerance without compromising anti-tumor efficacy.
Conclusions:
- Translating conventional radiobiology to HDF requires careful consideration of unique mechanisms.
- Clinical trials are crucial for validating HDF techniques and managing risks, especially with systemic treatments.
- Further prospective data is essential to evaluate the long-term risk/benefit ratio of various HDF and flash irradiation strategies.
More Related Videos
06:20Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
Published on: March 11, 2021
11:24Measuring DNA Damage and Repair in Mouse Splenocytes After Chronic In Vivo Exposure to Very Low Doses of Beta- and Gamma-Radiation
Published on: July 3, 2015
Related Concept Videos
Biological Effects of Radiation
Factors Affecting Drug Response: Overview
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Dose-Response Relationship: Overview
Bioavailability Study Design: Single Versus Multiple Dose Studies
Drug Accumulation During Multiple Dosing: Repetitive IV Injections